IRON vs BIIB: Which Stock is Better?
Side-by-side comparison of Disc Medicine Inc and Biogen Inc in 2026
IRON
Disc Medicine Inc
$70.18
BIIB
Biogen Inc
$180.54
Key Metrics Comparison
| Metric | IRON | BIIB | Winner |
|---|---|---|---|
| Market Cap | $2.69B | $26.50B | BIIB |
| P/E Ratio | N/A | 20.54 | BIIB |
| EPS (TTM) | $N/A | $8.79 | BIIB |
| Revenue Growth | 0.0% | -0.1% | BIIB |
| Gross Margin | 0.0% | 78.9% | BIIB |
Analyze IRON
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IRON or BIIB a better investment?
Comparing IRON and BIIB: Disc Medicine Inc has a market cap of $2.69B while Biogen Inc has $26.50B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IRON and BIIB?
IRON (Disc Medicine Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IRON or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IRON or BIIB?
IRON has higher revenue growth at 0.0% vs -0.1% for BIIB.
Which company is more profitable: IRON or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 0.0% for IRON.
Which is the larger company: IRON or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.50B compared to $2.69B for IRON.
Should I buy IRON or BIIB in 2026?
Both IRON and BIIB have investment merit. IRON trades at $70.18 while BIIB trades at $180.54. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IRON and BIIB stock?
Key differences: Market Cap ($2.69B vs $26.50B), P/E Ratio (N/A vs 20.5x), Revenue Growth (0.0% vs -0.1%), Gross Margin (0.0% vs 78.9%).